Medscape Oncology

💙 Living with systemic mastocytosis? Join our Community Exchange in Rosemont, IL! 🤝 Connect with SM experts, patients & caregivers, share experiences, and learn how to advocate for better care. 🍽️ Dinner provided. Space is limited—register now! mdsc.pe/4z6jAyI

LIVE TOMORROW ➡️ mdsc.pe/4k9208O Equip your practice with actionable insights on NTRK fusions in lung and thyroid cancer. 🗓️ November 6th ⏰ 12:00pm EST #Oncology #NTRKFusions #MedEd

🔄 Sequence matters in HER2-positive GEA. Dive into emerging anti-HER2 evidence, navigate treatment decisions across the patient journey & strengthen strategies for managing diarrhea and optimizing safety. 🤝 Advance your GEA approach—save your spot! mdsc.pe/4hk4FcR

How do you define refractory HSV when standard antivirals fail? Dr. Princy Kumar, Dr. Anna Wald, and Dr. Edoabasi McGee discuss key diagnostic clues and emerging oral therapies. Watch the full discussion ➡️ mdsc.pe/4A89e1B #InfectiousDisease #CME #MedEd

🧭 From diagnosis to coordinated care in adult PFIC & ALGS. Explore the multisystem nature of these genetic cholestatic liver diseases, identify where targeted therapies fit & build effective interprofessional care models. 🔬 Expand your expertise—join us! mdsc.pe/4h8ewDH

👉 Sharpen your approach to AL amyloidosis! 💬 Differentiate amyloid disorders, interpret treatment data, personalize therapy, and strengthen coordinated workflows to support timely, effective care. mdsc.pe/4x5jqGX #ASH26

🗣️ Better labs matter. So do better days. Discover how to navigate the move from first- to second-line PBC therapy, address symptoms and 🌿 biochemical parameters, and develop patient-centric management strategies. 🔬 Put the whole patient at the heart of PBC care—register today! mdsc.pe/4iRKdl

🎯 From clinical trials to patient care! Explore next-generation immuno-oncology approaches, identify patients who may benefit from antigen-directed therapies & navigate multidisciplinary requirements for clinical implementation. 🧬 Learn more! mdsc.pe/4sImjMH

Join our expert faculty LIVE as they discuss managing NTRK fusions in lung and thyroid cancer. 🗓️ November 6th ⏰ 12:00pm EST 🔗 mdsc.pe/4k9208O #Oncology #NTRKFusions #MedEd #CME #LungCancer

🪁 There’s more to hemophilia care than bleed counts. Explore clinically meaningful differences between therapies and learn how to match treatment to each patient’s disease, priorities, and needs. 🧭 Strengthen shared decisions across the care team. Join us! mdsc.pe/4irU5mb #ASH26

🧩 From mutations to management—connect the dots in CML care. Strengthen your approach to selecting TKIs before and after treatment failure, 🩸 apply mutational findings to therapy decisions & coordinate care across the team. ⚡ Advance your CML playbook—join us! mdsc.pe/4zRXX6p #ASH26

🧭 From diagnosis to coordinated care in adult PFIC & ALGS. Explore the multisystem nature of these genetic cholestatic liver diseases, identify where targeted therapies fit & build effective interprofessional care models. 🔬 Expand your expertise—join us! mdsc.pe/4h8ewDH

💙 Living with systemic mastocytosis? Join our Community Exchange in Rosemont, IL! 🤝 Connect with SM experts, patients & caregivers, share experiences, and learn how to advocate for better care. 🍽️ Dinner provided. Space is limited—register now! mdsc.pe/4z6jAyI

PBC treatment checkpoint: 🛑➡️🟢 First-line response falling short? Explore when to advance therapy, how to select second-line options, and 🧬 how to build management around what matters to the patient. 💬 Ready for the next step? Join us! mdsc.pe/4iRKdlN

🧬 Choosing the right TKI in CML starts with the right data. Explore first-line selection, navigate resistance & translate mutational analysis into therapeutic decisions with coordinated team-based care. 🎯 Sharpen your CML strategy—register today! mdsc.pe/4zRXX6p #ASH26

🧪 Systemic mastocytosis care is evolving across the disease spectrum. Explore recent clinical trial data, identify patients who may benefit from advanced treatment & ✨ evaluate whether disease control is truly adequate. 🧭 Stay ahead of SM care—register today! mdsc.pe/4yhO28u #ASH26

SAVE THE DATE 🗓️ Join Dr. Nabil F. Saba & Dr. Ibiayi Dagogo-Jack to explore clinical care insights on NTRK fusions across lung & thyroid cancer. 🗓️ Nov 6th ⏰ 12:00pm EST 🔗 mdsc.pe/4k9208O #Oncology #NTRKFusions

🩸 When rare hematologic conditions challenge the usual playbook, be ready. Decode atypical presentations, 🧬 explore novel targeted therapies & sharpen diagnostic and treatment strategies 🎯 Build confidence for complex cases—secure your spot today! mdsc.pe/46oDsAC #ASH26

🩸 From molecular profiling to treatment selection, MDS care continues to evolve! Explore emerging clinical evidence and strategies for managing treatment complexities across the disease continuum. 🎯 Advance your expertise! mdsc.pe/47pCQv9

🩸 At #ASH26, explore the latest data on bispecific antibodies for R/R DLBCL, including when transplant or CAR T may not be suitable. Gain practical insights to inform treatment decisions. Register today: mdsc.pe/4yldhag